GRP
RPRX icon

Global Retirement Partners’s Royalty Pharma RPRX Stock Holding History

Global Retirement Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
+7,549
New +$393K 0.01% 1119
2025
Q4 		$292K Sell
7,550
-1,290
-15% -$49.2K 0.01% 1256
2025
Q3 		$312K Buy
8,840
+8,420
+2,005% +$305K 0.01% 972
2025
Q2 		$15.1K Buy
+420
New +$13.9K ﹤0.01% 2416
2024
Q4 		$536 Sell
21
-35
-63% -$928 ﹤0.01% 3387
2024
Q3 		$1.58K Sell
56
-8
-13% -$222 ﹤0.01% 3005
2024
Q2 		$1.69K Buy
64
+46
+256% +$1.27K ﹤0.01% 3031
2024
Q1 		$547 Hold
18
– – ﹤0.01% 3117
2023
Q4 		$511 Buy
+18
New +$495 ﹤0.01% 3077
2023
Q2 		– Sell
-8
Closed -$283 – 3243
2023
Q1 		$283 Sell
8
-25
-76% -$927 ﹤0.01% 3044
2022
Q4 		$1.3K Buy
33
+3
+10% +$125 ﹤0.01% 2506
2022
Q3 		$1K Buy
+30
New +$1.28K ﹤0.01% 2569
2021
Q1 		– Sell
-49
Closed -$2K – 1879
2020
Q4 		$2K Buy
49
+9
+23% +$382 ﹤0.01% 1626
2020
Q3 		$2K Sell
40
-75
-65% -$3.22K ﹤0.01% 1506
2020
Q2 		$6K Buy
+115
New +$5.69K ﹤0.01% 1258

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's RPRX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Royalty Pharma (RPRX) in Q2 2026: 7,549 shares worth $423K. The stake represents 0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RPRX as recently as Q4 2025.

Global Retirement Partners first reported a position in RPRX in Q2 2020 and has held it in 15 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Global Retirement Partners held 7,549 shares of Royalty Pharma worth $423K as of Q2 2026.
  • Royalty Pharma was a new Global Retirement Partners position in Q2 2026.
  • Royalty Pharma made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1119 holding.
  • Global Retirement Partners first reported a position in Royalty Pharma in Q2 2020 and has held it in 15 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.